{"log_id": 8788625536080707093, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 0, "average": 0.999754, "min": 0.9995}, "location": {"width": 98, "top": 253, "height": 29, "left": 205}, "words": "药理作用"}, {"probability": {"variance": 0.000543, "average": 0.993838, "min": 0.864468}, "location": {"width": 806, "top": 293, "height": 37, "left": 246}, "words": "本品是新型的4—苯胺喹唑啉类酶抑制剂,具有独特的作用机制,能够选择性的"}, {"probability": {"variance": 0.000258, "average": 0.991814, "min": 0.931516}, "location": {"width": 847, "top": 341, "height": 34, "left": 207}, "words": "可逆的抑制表皮生长因子受体ErbB1和/或ErbB2胞内的酪氨酸激酶结构域(估计K"}, {"probability": {"variance": 5.7e-05, "average": 0.996041, "min": 0.96388}, "location": {"width": 864, "top": 385, "height": 37, "left": 207}, "words": "值分别是3nM和13nM),结合后解离慢(半衰期≥300分钟)。本品的这种解离率比"}, {"probability": {"variance": 8.8e-05, "average": 0.996343, "min": 0.944165}, "location": {"width": 877, "top": 431, "height": 36, "left": 207}, "words": "其他的4—苯胺喹唑啉类酶抑制剂要慢。本品在体外研究和多种动物模型中显示能抑制"}, {"probability": {"variance": 1.9e-05, "average": 0.996013, "min": 0.985192}, "location": {"width": 263, "top": 482, "height": 29, "left": 207}, "words": "EbB引起的肿瘤细胞生长"}, {"probability": {"variance": 0.00247, "average": 0.990781, "min": 0.696812}, "location": {"width": 830, "top": 524, "height": 33, "left": 248}, "words": "本品不仅单药具有活性,在体外研究中显示其与5-氟尿嘧啶(卡培他滨的活性代"}, {"probability": {"variance": 2e-06, "average": 0.999267, "min": 0.993852}, "location": {"width": 861, "top": 569, "height": 36, "left": 207}, "words": "谢产物)联合在4个肿瘤细胞系中均有抗肿瘤活性。这些体外研究数据的临床意义还"}, {"probability": {"variance": 0, "average": 0.999633, "min": 0.999301}, "location": {"width": 68, "top": 623, "height": 26, "left": 213}, "words": "不清楚"}, {"probability": {"variance": 4e-06, "average": 0.998601, "min": 0.99159}, "location": {"width": 835, "top": 660, "height": 37, "left": 248}, "words": "在曲妥珠单抗耐受的细胞系中评价了本品对细胞生长的抑制作用。对在曲妥珠单抗"}, {"probability": {"variance": 1e-06, "average": 0.999245, "min": 0.995768}, "location": {"width": 881, "top": 706, "height": 35, "left": 208}, "words": "培养基中可长期生长的乳腺癌细胞系,本品有明显抑制作用。这些研究显示这两种针对"}, {"probability": {"variance": 2.5e-05, "average": 0.997801, "min": 0.978142}, "location": {"width": 369, "top": 756, "height": 29, "left": 210}, "words": "EbB2靶点的药物间不存在交叉耐药"}, {"probability": {"variance": 0.002209, "average": 0.981236, "min": 0.787664}, "location": {"width": 800, "top": 797, "height": 35, "left": 249}, "words": "联合表达ErbB2的激素敏感乳腺癌细胞(雌激素受体[ER]阳性和/或孕激素受体"}, {"probability": {"variance": 8.7e-05, "average": 0.996911, "min": 0.947951}, "location": {"width": 863, "top": 843, "height": 36, "left": 213}, "words": "PgR]阳性)有对现有的内分泌疗法耐药的倾向。在肿瘤产生耐药的过程中,最初缺乏"}, {"probability": {"variance": 0.000196, "average": 0.995246, "min": 0.914972}, "location": {"width": 830, "top": 889, "height": 34, "left": 209}, "words": "ErbB1或ErbB2的激素敏感乳腺癌细胞逐渐可以调节这些抗体。随机临床试验显示"}, {"probability": {"variance": 0.00019, "average": 0.993859, "min": 0.934932}, "location": {"width": 873, "top": 935, "height": 35, "left": 210}, "words": "EbB2或 Erbbl酪氨酸激酶抑制剂可以相应的改善内分泌疗法治疗激素敏感乳腺癌的疗"}, {"probability": {"variance": 0, "average": 0.999991, "min": 0.999991}, "location": {"width": 28, "top": 986, "height": 28, "left": 209}, "words": "效"}, {"probability": {"variance": 4e-06, "average": 0.998348, "min": 0.995033}, "location": {"width": 97, "top": 1051, "height": 27, "left": 210}, "words": "毒理研究"}, {"probability": {"variance": 0, "average": 0.973831, "min": 0.973831}, "location": {"width": 95, "top": 1090, "height": 26, "left": 916}, "words": " GUANGDONG"}, {"probability": {"variance": 0, "average": 0.664345, "min": 0.664345}, "location": {"width": 23, "top": 1101, "height": 22, "left": 1020}, "words": " HA"}, {"probability": {"variance": 2e-06, "average": 0.999038, "min": 0.996546}, "location": {"width": 95, "top": 1116, "height": 27, "left": 210}, "words": "遗传毒性"}, {"probability": {"variance": 0.004582, "average": 0.951873, "min": 0.836224}, "location": {"width": 231, "top": 1115, "height": 56, "left": 867}, "words": "华润广东"}, {"probability": {"variance": 2.4e-05, "average": 0.997122, "min": 0.984046}, "location": {"width": 582, "top": 1178, "height": 33, "left": 271}, "words": "在中国仓鼠染色体畸变试验、微生物致突变(Ames)试验"}, {"probability": {"variance": 0.033208, "average": 0.559153, "min": 0.371794}, "location": {"width": 182, "top": 1169, "height": 44, "left": 900}, "words": "已细"}, {"probability": {"variance": 1.8e-05, "average": 0.998323, "min": 0.976659}, "location": {"width": 695, "top": 1225, "height": 29, "left": 212}, "words": "变试验或体内大鼠骨髓染色体畸变试验中,单剂剂量达2000mg/kg时"}, {"probability": {"variance": 9.3e-05, "average": 0.995753, "min": 0.942022}, "location": {"width": 878, "top": 1269, "height": 30, "left": 211}, "words": "变或致突变作用。药品中的杂质(达4ppm或8mcg/d)在体外和体内单独试验中显示有"}, {"probability": {"variance": 1e-06, "average": 0.999368, "min": 0.998115}, "location": {"width": 95, "top": 1319, "height": 26, "left": 210}, "words": "遗传毒性"}, {"probability": {"variance": 0, "average": 0.999651, "min": 0.998917}, "location": {"width": 96, "top": 1384, "height": 27, "left": 212}, "words": "生殖毒性"}, {"probability": {"variance": 1e-06, "average": 0.998101, "min": 0.997352}, "location": {"width": 25, "top": 1536, "height": 24, "left": 644}, "words": "22"}], "language": 3}